References
- Tada T, Zhan H, Tanaka Y, Intraventricular administration of hepatocyte growth factor treats mouse communicating hydrocephalus induced by transforming growth factor beta1. Neurobiol Dis 2006;21:576–86.
- Lipina R, Reguli S, Novackova L, Relation between TGF-beta 1 levels in cerebrospinal fluid and ETV outcome in premature newborns with posthemorrhagic hydrocephalus. Childs Nerv Syst 2010;26:333–41.
- Douglas MR, Daniel M, Lagord C, High CSF transforming growth factor beta levels after subarachnoid haemorrhage: association with chronic communicating hydrocephalus. J Neurol Neurosurg Psychiatry 2009;80:545–50.
- Cherian S, Thoresen M, Silver IA, Transforming growth factor-betas in a rat model of neonatal posthaemorrhagic hydrocephalus. Neuropathol Appl Neurobiol 2004;30:585–600.
- Trusolino L, Bertotti A, Comoglio PM. MET signalling: principles and functions in development, organ regeneration and cancer. Nat Rev Mol Cell Biol 2010;11:834–48.
- Yasuda H, Imai E, Shiota A, Antifibrogenic effect of a deletion variant of hepatocyte growth factor on liver fibrosis in rats. Hepatology 1996;24:636–42.
- Ramadori G, Neubauer K, Odenthal M, The gene of hepatocyte growth factor is expressed in fat-storing cells of rat liver and is downregulated during cell growth and by transforming growth factor-beta. Biochem Biophys Res Commun 1992;183:739–42.
- Jeong SR, Kwon MJ, Lee HG, Hepatocyte growth factor reduces astrocytic scar formation and promotes axonal growth beyond glial scars after spinal cord injury. Exp Neurol 2012;233:312–22.
- Gong R, Rifai A, Tolbert EM, Hepatocyte growth factor modulates matrix metalloproteinases and plasminogen activator/plasmin proteolytic pathways in progressive renal interstitial fibrosis. J Am Soc Nephrol 2003;14:3047–60.
- Liu Y, Rajur K, Tolbert E, Endogenous hepatocyte growth factor ameliorates chronic renal injury by activating matrix degradation pathways. Kidney Int 2000;58:2028–43.
- Karsdal MA, Madsen SH, Christiansen C, Cartilage degradation is fully reversible in the presence of aggrecanase but not matrix metalloproteinase activity. Arthritis Res Ther 2008;10:R63.
- Zhen EY, Brittain IJ, Laska DA, Characterization of metalloprotease cleavage products of human articular cartilage. Arthritis Rheum 2008;58:2420–31.
- Barascuk N, Veidal SS, Larsen L, A novel assay for extracellular matrix remodeling associated with liver fibrosis: an enzyme-linked immunosorbent assay (ELISA) for a MMP-9 proteolytically revealed neo-epitope of type III collagen. Clin Biochem 2010;43:899–904.
- Kirimlioglu H, Kirimlioglu V, Yilmaz S. Expression of matrix metalloproteinases 2 and 9 in donor liver, cirrhotic liver, and acute rejection after human liver transplantation. Transplant Proc 2008;40:3574–7.
- Gieling RG, Wallace K, Han YP. Interleukin-1 participates in the progression from liver injury to fibrosis. Am J Physiol Gastrointest Liver Physiol 2009;296:G1324–31.
- Okamoto T, Takahashi S, Nakamura E, Increased expression of matrix metalloproteinase-9 and hepatocyte growth factor in the cerebrospinal fluid of infants with posthemorrhagic hydrocephalus. Early Hum Dev 2010;86:251–4.
- Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 2003;92:827–39.
- Okamoto T, Takahashi S, Nakamura E, Matrix metalloproteinases in infants with posthemorrhagic hydrocephalus. Early Hum Dev 2008;84:137–9.
- Slobodian I, Krassioukov-Enns D, Del Bigio MR. Protein and synthetic polymer injection for induction of obstructive hydrocephalus in rats. Cerebrospinal Fluid Res 2007;4:9.
- Hayashi N, Leifer DW, Cohen AR. Chronologic changes of cerebral ventricular size in a transgenic model of hydrocephalus. Pediatr Neurosurg 2000;33:182–7.
- Aquilina K, Hobbs C, Cherian S, A neonatal piglet model of intraventricular hemorrhage and posthemorrhagic ventricular dilation. J Neurosurg 2007;107:126–36.
- Hwang YS, Shim I, Chang JW. Anxiety responses and neurochemical changes in a kaolin-induced rat model of hydrocephalus. J Neurosurg Pediatr 2011;7:401–7.
- Lopes Lda S, Slobodian I, Del Bigio MR. Characterization of juvenile and young adult mice following induction of hydrocephalus with kaolin. Exp Neurol 2009;219:187–96.
- Nagra G, Wagshul ME, Rashid S, Elevated CSF outflow resistance associated with impaired lymphatic CSF absorption in a rat model of kaolin-induced communicating hydrocephalus. Cerebrospinal Fluid Res 2010;7:4.
- Bulat M, Klarica M. Recent insights into a new hydrodynamics of the cerebrospinal fluid. Brain Res Rev 2011;65:99–112.
- Oreskovic D, Klarica M. The formation of cerebrospinal fluid: nearly a hundred years of interpretations and misinterpretations. Brain Res Rev 2010;64:241–62.
- Deren KE, Packer M, Forsyth J, Reactive astrocytosis, microgliosis and inflammation in rats with neonatal hydrocephalus. Exp Neurol 2010;226:110–9.
- Xu H, Zhang SL, Tan GW, Reactive gliosis and neuroinflammation in rats with communicating hydrocephalus. Neuroscience 2012;218:317–25.
- Buckwalter MS, Wyss-Coray T. Modelling neuroinflammatory phenotypes in vivo. J Neuroinflammation 2004;1:10.
- Boche D, Cunningham C, Gauldie J, Transforming growth factor-beta 1-mediated neuroprotection against excitotoxic injury in vivo. J Cereb Blood Flow Metab 2003;23:1174–82.
- Wyss-Coray T, Lin C, Sanan DA, Chronic overproduction of transforming growth factor-beta1 by astrocytes promotes Alzheimer's disease-like microvascular degeneration in transgenic mice. Am J Pathol 2000;156:139–50.
- Watanabe T, Tajima H, Hironori H, Sodium valproate blocks the transforming growth factor (TGF)-beta1 autocrine loop and attenuates the TGF-beta1-induced collagen synthesis in a human hepatic stellate cell line. Int J Mol Med 2011;28:919–25.
- Li M, Krishnaveni MS, Li C, Epithelium-specific deletion of TGF-beta receptor type II protects mice from bleomycin-induced pulmonary fibrosis. J Clin Invest 2011;121:277–87.
- Lei B, Hitomi H, Mori T, Effect of efonidipine on TGF-beta1-induced cardiac fibrosis through Smad2-dependent pathway in rat cardiac fibroblasts. J Pharmacol Sci 2011;117:98–105.
- Biernacka A, Dobaczewski M, Frangogiannis NG. TGF-beta signaling in fibrosis. Growth Factors 2011;29:196–202.
- Mizuno S, Matsumoto K, Kurosawa T, Reciprocal balance of hepatocyte growth factor and transforming growth factor-beta 1 in renal fibrosis in mice. Kidney Int 2000;57:937–48.
- Kwiecinski M, Noetel A, Elfimova N, Hepatocyte growth factor (HGF) inhibits collagen I and IV synthesis in hepatic stellate cells by miRNA-29 induction. PLoS One 2011;6: e24568.
- Jones CN, Tuleuova N, Lee JY, Cultivating hepatocytes on printed arrays of HGF and BMP7 to characterize protective effects of these growth factors during in vitro alcohol injury. Biomaterials 2010;31:5936–44.
- Ruppert C, Markart P, Wygrecka M, Role of coagulation and fibrinolysis in lung and renal fibrosis. Hamostaseologie 2008;28:30–2, 34–6.
- Fan JM, Ng YY, Hill PA, Transforming growth factor-beta regulates tubular epithelial-myofibroblast transdifferentiation in vitro. Kidney Int 1999;56:1455–67.
- Whitelaw A, Cherian S, Thoresen M, Posthaemorrhagic ventricular dilatation: new mechanisms and new treatment. Acta Paediatr Suppl 2004;93:11–4.
- Okamoto T, Takahashi S, Nakamura E, Transforming growth factor-beta1 induces matrix metalloproteinase-9 expression in human meningeal cells via ERK and Smad pathways. Biochem Biophys Res Commun 2009;383:475–9.